XML 43 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share Capital (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock Option Activity

The following table presents the summary of stock option activity for the period:

 

 

 

Number of

 

 

Weighted
Average
Exercise

 

 

Aggregate

 

 

 

Options

 

 

Price ($)(1)

 

 

Intrinsic Value

 

Outstanding, December 31, 2020

 

 

4,758,997

 

 

 

9.10

 

 

 

30,464

 

Granted

 

 

1,775,450

 

 

 

19.82

 

 

 

 

Exercised(2)

 

 

(690,284

)

 

 

7.34

 

 

 

11,306

 

Forfeited, cancelled or expired

 

 

(205,931

)

 

 

13.01

 

 

 

 

Outstanding, December 31, 2021

 

 

5,638,232

 

 

 

12.55

 

 

 

105,405

 

Granted

 

 

2,315,645

 

 

 

30.90

 

 

 

 

Exercised(2)

 

 

(780,725

)

 

 

9.47

 

 

 

19,651

 

Forfeited, cancelled or expired

 

 

(55,370

)

 

 

24.50

 

 

 

 

Outstanding, December 31, 2022

 

 

7,117,782

 

 

 

18.75

 

 

 

147,214

 

Granted

 

 

2,542,473

 

 

 

35.29

 

 

 

 

Exercised(2)

 

 

(587,536

)

 

 

13.58

 

 

 

14,526

 

Forfeited, cancelled or expired

 

 

(178,217

)

 

 

31.49

 

 

 

 

Outstanding, December 31, 2023

 

 

8,894,502

 

 

 

23.56

 

 

 

200,122

 

Exercisable, December 31, 2023

 

 

4,789,178

 

 

 

16.23

 

 

 

142,900

 

 

(1)
Canadian dollar denominated stock options have been translated into U.S. dollars at a foreign exchange rate of 0.76 (2022 – 0.74 and 2021 – 0.79) as of December 31, 2023.

 

(2)
During the year ended December 31, 2023, 4,320 (2022 – 68,930 and 2021 – 66,215) stock options were exercised for the same number of common shares in exchange for cash. In the same period, the Company issued 377,114 (2022 – 510,671 and 2021 – 412,940) common shares for the cashless exercise of 583,216 (2022 – 711,795 and 2021 – 624,069) stock options.
Schedule of Nonvested Stock Option Activity

A summary of the Company’s non-vested stock option activity and related information for the year ended December 31, 2023 is as follows:

 

 

 

Number of
Options

 

 

Weighted Average
Grant Date
Fair Value ($)

 

Non-vested, January 1, 2023

 

 

3,587,374

 

 

 

16.60

 

Granted

 

 

2,542,473

 

 

 

22.52

 

Vested

 

 

(1,847,714

)

 

 

15.82

 

Forfeited or cancelled

 

 

(176,809

)

 

 

18.62

 

Non-vested, December 31, 2023

 

 

4,105,324

 

 

 

20.53

 

Fair Value Assumptions for Stock Options

The weighted-average option pricing assumptions are as follows:

 

 

 

Year Ended December 31,

 

 

 

 

2023

 

 

2022

 

 

2021

 

 

Average risk-free interest rate

 

 

3.93

%

 

 

2.39

%

 

 

1.16

%

 

Expected volatility

 

 

69

%

 

 

70

%

 

 

68

%

 

Average expected term (in years)

 

 

5.94

 

 

 

6.16

 

 

 

6.66

 

 

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

 

Weighted average fair value of options granted

 

$

22.52

 

 

$

19.78

 

 

$

12.54

 

 

Stock Based Compensation Expenses

Stock-based compensation expense is classified in the consolidated statements of operations and comprehensive income (loss) as follows:

 

 

 

Year Ended December 31,

 

 

 

 

2023

 

 

2022

 

 

2021

 

 

Research and development expenses

 

$

13,067

 

 

$

7,766

 

 

$

3,734

 

 

General and administrative expenses

 

 

19,305

 

 

 

12,610

 

 

 

6,283

 

 

 

 

$

32,372

 

 

$

20,376

 

 

$

10,017

 

 

Schedule Of Pre-Funded Warrants Activity

The following table summarizes the pre-funded warrants activity for the years ended December 31, 2023, 2022, and 2021:

 

 

 

Date of issuance

 

 

 

 

 

 

March 2021

 

 

October 2021

 

 

June 2022

 

 

December 2023

 

 

Total

 

Outstanding, December 31, 2020

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Issued

 

 

1,081,081

 

 

 

1,694,915

 

 

 

—

 

 

 

—

 

 

 

2,775,996

 

Exercised

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Outstanding, December 31, 2021

 

 

1,081,081

 

 

 

1,694,915

 

 

 

—

 

 

 

—

 

 

 

2,775,996

 

Issued

 

 

—

 

 

 

—

 

 

 

327,868

 

 

 

—

 

 

 

327,868

 

Exercised

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Outstanding, December 31, 2022

 

 

1,081,081

 

 

 

1,694,915

 

 

 

327,868

 

 

 

—

 

 

 

3,103,864

 

Issued

 

 

—

 

 

 

—

 

 

 

—

 

 

 

769,230

 

 

 

769,230

 

Exercised

 

 

(1,081,081

)

 

 

(618,932

)

 

 

—

 

 

 

—

 

 

 

(1,700,013

)

Outstanding, December 31, 2023

 

 

—

 

 

 

1,075,983

 

 

 

327,868

 

 

 

769,230

 

 

 

2,173,081